Prognostic factors in cryptococcal meningoencephalitis

被引:5
作者
Darzé, C
Lucena, R
Gomes, I
Melo, A
机构
[1] Univ Fed Bahia, Div Neuroinfectol & Neuroepidemiol, BR-41170290 Salvador, BA, Brazil
[2] Univ Fed Bahia, Hosp Univ Professor Edgard Santos, Serv Neurol, BR-41170290 Salvador, BA, Brazil
关键词
cryptococcosis; Cryptococcus neoformans; meningitis; meningoencephalitis; prognosis;
D O I
10.1590/S0004-282X1999000400018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Objective: To identify demographic, clinical and cerebrospinal fluid (CSF) variables associated to intrahospitalar lethality of patients with cryptococcal meningoencephalitis. Study design: Retrospective cohort to study prognosis. Setting: Hospital Couto Maia (HCMaia) reference for patients with infectious diseases in the State of Bahia Northeastern Brazil. Population: Patients admitted at HCMaia, from 1972 to 1996, with the diagnosis of cryptococcal meningoencephalitis. Results: Lethality rate was 42.7%. The most important neurological abnormalities were neck stiffness, decreased consciousness level, behavior changes, cranial nerve palsy and Visual alterations. Disease time over 30 days, involvement of consciousness level and cerebrospinal fluid cells under 40/mm(3) were associated to a higher lethality rate. Conclusion: Disease time over 30 days, involvement of consciousness level, and CSF decreased cellularity were the only predictors of lethality in the studied population.
引用
收藏
页码:649 / 652
页数:4
相关论文
共 50 条
  • [41] Intraspecies variation in the efficacy of adjunctive recombinant interferon-γ therapy against cryptococcal meningoencephalitis in mice
    Ikeda-Dantsuji, Yurika
    Nakamura, Shigeki
    Ohno, Hideaki
    Inukai, Tatsuya
    Nagi, Minoru
    Ueno, Keigo
    Umeyama, Takashi
    Kinjo, Yuki
    Yamagoe, Satoshi
    Shibuya, Kazutoshi
    Miyazaki, Yoshitsugu
    MEDICAL MYCOLOGY, 2018, 56 (03) : 382 - 386
  • [42] Pharmacodynamics of Liposomal Amphotericin B and Flucytosine for Cryptococcal Meningoencephalitis: Safe and Effective Regimens for Immunocompromised Patients
    O'Connor, Lucy
    Livermore, Joanne
    Sharp, Andrew D.
    Goodwin, Joanne
    Gregson, Lea
    Howard, Susan J.
    Felton, Timothy W.
    Schwartz, Julie A.
    Neely, Michael N.
    Harrison, Thomas S.
    Perfect, John R.
    Hope, William W.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (02) : 351 - 361
  • [43] Cryptococcal meningoencephalitis with Actinomyces odontolyticus sepsis: a case report and literature review
    Qingyu Huang
    Zhuquan Hong
    Quanlong Hong
    BMC Infectious Diseases, 23
  • [44] Cryptococcal Meningoencephalitis Related to HIV Infection with Resistance to Fluconazole, Relapse, and IRIS
    Seilmaier, Michael
    Hecht, Anna
    Guggemos, Wolfgang
    Rudisser, Klaus
    MEDIZINISCHE KLINIK, 2009, 104 (01) : 58 - 62
  • [45] Importance of Follow-Up Cerebrospinal Fluid Analysis in Cryptococcal Meningoencephalitis
    Skripuletz, Thomas
    Schwenkenbecher, Philipp
    Pars, Kaweh
    Stoll, Matthias
    Conzen, Josef
    Bolat, Seza
    Pul, Refik
    Vonberg, Ralf-Peter
    Sedlacek, Ludwig
    Wurster, Ulrich
    Stangel, Martin
    Trebst, Corinna
    DISEASE MARKERS, 2014, 2014
  • [46] Fulminant cryptococcal meningoencephalitis after successful treatment of primary cutaneous cryptococcosis
    Romiopoulos, Iordanis
    Pana, Zoi Dorothea
    Pyrpasopoulou, Athina
    Linardou, Ioanna
    Avdelidi, Eugenia
    Sidiropoulou, Maria
    Chatzidrosou, Eleni
    Ioannides, Dimitrios
    Karagiannis, Asterios
    Roilides, Emmanuel
    GERMS, 2020, 10 (04): : 388 - 391
  • [47] Neurogenic pulmonary edema following Cryptococcal meningoencephalitis associated with HIV infection
    Kondo, Reiichiro
    Sugita, Yasuo
    Arakawa, Kenji
    Nakashima, Shinji
    Umeno, Yumi
    Todoroki, Keita
    Yoshida, Tomoko
    Takase, Yorihiko
    Kage, Masayoshi
    Oshima, Koichi
    Yano, Hirohisa
    NEUROPATHOLOGY, 2015, 35 (04) : 343 - 347
  • [48] Limited Activity of Miltefosine in Murine Models of Cryptococcal Meningoencephalitis and Disseminated Cryptococcosis
    Wiederhold, Nathan P.
    Najvar, Laura K.
    Bocanegra, Rosie
    Kirkpatrick, William R.
    Sorrell, Tania C.
    Patterson, Thomas F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (02) : 745 - 750
  • [49] A retrospective study of contributing factors for prognosis and survival length of cryptococcal meningoencephalitis in Southern part of China (1998-2013)
    Zheng, Hui
    Li, Mingyue
    Luo, Yingting
    Wang, Dongmei
    Yang, Jialing
    Chen, Qiong
    Lao, Junying
    Chen, Ningfen
    Yang, Man
    Wang, Qun
    BMC INFECTIOUS DISEASES, 2015, 15
  • [50] Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis
    Lu, R.
    Hollingsworth, C.
    Qiu, J.
    Wang, A.
    Hughes, E.
    Xin, X.
    Konrath, K. M.
    Elsegeiny, W.
    Park, Yoon-Dong
    Atakulu, L.
    Craft, J. C.
    Tramont, E. C.
    Mannino, R.
    Williamson, P. R.
    MBIO, 2019, 10 (03):